Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients

Clinical Endocrinology

Volumn 69, Issue 4, 2008, Pages 608-612

  Ronchi, C L ^a   Ferrante, E ^a   Rizzo, E ^a   Giavoli, C ^a   Verrua, E ^a   Bergamaschi, S ^b   Lania, A G ^b,c   Beck Peccoz, P ^b   Spada, A ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c Endocrinology and Diabetology Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; CORTICOTROPIN; CORTISONE ACETATE; GROWTH HORMONE; HYDROCORTISONE; OCTREOTIDE; PEGVISOMANT; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; TETRACOSACTIDE;

ACROMEGALY; ADRENAL INSUFFICIENCY; ARTICLE; CLINICAL ARTICLE; EMPTY SELLA SYNDROME; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPOPHYSIS ADENOMA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSSPHENOIDAL SURGERY;

ACROMEGALY; ADENOMA; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; BASAL METABOLISM; DELAYED-ACTION PREPARATIONS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PITUITARY-ADRENAL SYSTEM; RETROSPECTIVE STUDIES; SOMATOSTATIN; TIME FACTORS;

EID: 51649098111     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03270.x     Document Type: Article

References (20)

1. Vance, M.L. Laws, E.R. Jr. (2005) Role of medical therapy in the management of acromegaly. Neurosurgery, 56, 877 885.
2. Freda, P.U., Katznelson, L., van der Lely, A.J., Reyes, C.M., Zhao, S. Rabinowitz, D. (2005) Long-acting somatostatin analog therapy of acromegaly: a meta-analysis. Journal of Clinical Endocrinology and Metabolism, 90, 4465 4473.
3. Biermasz, N.R. (2005) Current pharmacotherapy for acromegaly: a review. Expert Opinion on Pharmacotherapy, 6, 2393 2405.
4. Melmed, S. (2006) Medical progress: Acromegaly. New England Journal of Medicine, 355, 2558 2573.
5. Jenkins, P.J., Bates, P., Carson, M.N., Stewart, P.M. Wass, J.A. (2006) Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 91, 1239 1245.
6. Swearingen, B., Barker, F.G., II, Katznelson, L., Biller, B.M., Grinspoon, S., Klibanski, A., Moayeri, N., Black, P.M. Zervas, N.T. (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 3419 3426.
7. Nomikos, P., Buchfelder, M. Fahlbusch, R. (2005) The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'. European Journal of Endocrinology, 152, 379 387.
8. Beauregard, C., Truong, U., Hardy, J. Serri, O. (2003) Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clinical Endocrinology, 58, 86 91.
9. Klose, M., Lange, M., Kosteljanetz, M., Poulsgaard, L. Feldt-Rasmussen, U. (2005) Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen test. Clinical Endocrinology, 63, 499 505.
10. Abbassioun, K., Amirjamshidi, M., Mehrazin, A., Khalatbary, I., Keynama, M., Bokai, H. Abdollahi, M. (2006) A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years. Surgical Neurology, 66, 26 31.
11. Tominaga, A., Uozumi, T., Arita, K., Kurisu, K., Yano, T. Hirohata, T. (1995) Anterior pituitary function in patients with nonfunctioning pituitary adenoma: results of longitudinal follow-up. Endocrine Journal, 42, 421 427.
12. Beck-Peccoz, P., Brucker-Davis, F., Persani, L., Smallridge, R.C. Weintraub, B.D. (1996) Thyrotropin-secreting pituitary tumors. Endocrine Reviews, 17, 610 638.
13. Giustina, A., Barman, A., Casanueva, F.F., Cavagnini, F., Frohman, L., Ho, K., Veldhuis, J., Wass, J., Von Werder, K. Melmed, S. (2000) Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism, 85, 526 529.
14. Ambrosi, B., Barbetta, L., Re, T., Passini, E. Faglia, G. (1998) The one microgram adrenocorticotropin test in the assessment of hypothalamic-pituitary- adrenal function. European Journal of Endocrinology, 139, 575 579.
15. Tordjman, K., Jaffe, A., Trostanetsky, Y., Greenman, Y., Limor, R. Stern, N. (2000) Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test. Clinical Endocrinology, 52, 633 640.
16. Epaminonda, P., Porretti, S., Cappiello, V., Faglia, G. Arosio, M. (2001) Efficacy of radiotherapy in normalizing serum IGF-I, acid-labil subunit (ALS) and IGF-BP3 levels in acromegaly. Clinical Endocrinology, 55, 183 189.
17. Van der Hoek, J., Lamberts, S.W. Hofland, L.J. (2004) The role of somatostatin analogues in Cushing's disease. Pituitary, 7, 257 264.
18. Vance, M.L. (1994) Hypopituitarism. New England Journal of Medicine, 330, 1651 1662.
19. Greenman, Y., Tordjman, K., Kisch, E., Razon, N., Ouaknine, G. Stern, N. (1995) Relative sparing of anterior pituitary function in patients with growth hormone-secreting macroadenomas: comparison with nonfunctioning macroadenomas. Journal of Clinical Endocrinology and Metabolism, 80, 1577 1583.
20. Damjanovic, S.S., Popovic, V.P., Petakov, M.S., Nikolic-Durovic, M.M., Doknic, M.Z. Gligorovic, M.S. (1996) Gonadotrophin and free α-subunit secretion in patients with acromegaly and clinically non-functioning pituitary tumors: anterior pituitary function and the effect of thyrotrophin-releasing hormone. Journal of Endocrinological Investigation, 19, 663 669.